CD274 and neoplasm: In addition, previous studies confirmed that tumor immunity-associated biomarkers, such as tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1), are related to the treatment response and prognosis of BCa24–27.